|
ES2028074T3
(es)
*
|
1986-06-13 |
1992-07-01 |
Alza Corporation |
Activacion por humedad de un sistema de suministro transdermico de farmacos.
|
|
US5176917A
(en)
*
|
1989-03-15 |
1993-01-05 |
Lts Lohmann |
Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
|
|
US5116620A
(en)
*
|
1989-11-21 |
1992-05-26 |
Bruce A. Barber |
Antimicrobial wound dressing
|
|
US5104660A
(en)
*
|
1989-11-21 |
1992-04-14 |
Bruce A. Barber |
Method of preparing an antimicrobial wound dressing
|
|
US5227168A
(en)
*
|
1989-11-21 |
1993-07-13 |
Bruce Barber |
Method of treating a wound
|
|
US6132849A
(en)
*
|
1990-10-30 |
2000-10-17 |
Minnesota Mining And Manufacturing Company |
Receptive media for permanent imaging and methods of preparing and using same
|
|
US5443727A
(en)
*
|
1990-10-30 |
1995-08-22 |
Minnesota Mining And Manufacturing Company |
Articles having a polymeric shell and method for preparing same
|
|
CA2076574A1
(en)
*
|
1991-10-01 |
1993-04-02 |
John Lenneis Haynes |
Extended-life drug filled patch
|
|
EP0755244A1
(en)
*
|
1994-04-13 |
1997-01-29 |
Novartis AG |
Temporally controlled drug delivery systems
|
|
GB9515807D0
(en)
*
|
1995-08-02 |
1995-10-04 |
Cantwell Evelyna D |
Topical hyperbaric bandage
|
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
|
US6797276B1
(en)
*
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
|
US6019997A
(en)
*
|
1997-01-09 |
2000-02-01 |
Minnesota Mining And Manufacturing |
Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
|
|
US7150881B2
(en)
*
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
|
WO2000037058A1
(en)
|
1998-12-18 |
2000-06-29 |
Alza Corporation |
Transparent transdermal nicotine delivery devices
|
|
WO2000048541A1
(en)
*
|
1999-02-19 |
2000-08-24 |
Brooks Norman A |
Zinc chloride in treating skin diseases
|
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
|
ES2244422T3
(es)
*
|
1999-04-01 |
2005-12-16 |
Alza Corporation |
Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
|
|
EP1165132B1
(en)
*
|
1999-04-08 |
2011-10-19 |
Intercell USA, Inc. |
Dry formulation for transcutaneous immunization
|
|
US6812205B2
(en)
|
2000-03-15 |
2004-11-02 |
The Brigham & Women's Hospital, Inc. |
Suppression of vascular disorders by mucosal administration of heat shock protein peptides
|
|
KR20040007413A
(ko)
*
|
2000-11-03 |
2004-01-24 |
바이오메디신즈 인코포레이티드 |
단기 및 장기 약물 약량측정 방법
|
|
WO2002064162A2
(en)
*
|
2001-02-13 |
2002-08-22 |
Government Of The United States, As Represented By The Secretary Of The Army |
Vaccine for transcutaneous immunization
|
|
US20030060873A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Nanomedical Technologies, Inc. |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
US7776379B2
(en)
*
|
2001-09-19 |
2010-08-17 |
Medlogics Device Corporation |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
CN100438870C
(zh)
*
|
2001-11-09 |
2008-12-03 |
精达制药公司 |
ω干扰素在制备治疗温血动物对象中病毒性疾病的药物中的用途
|
|
EP1549254A4
(en)
*
|
2002-09-27 |
2007-11-07 |
Medlogics Device Corp |
IMPLANTABLE STENT WITH MODIFIED ENDS
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
|
EP1682211B1
(en)
|
2003-10-27 |
2009-11-18 |
Universität Basel |
Transdermal drug delivery system
|
|
US7208172B2
(en)
*
|
2003-11-03 |
2007-04-24 |
Medlogics Device Corporation |
Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices
|
|
US20050119723A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Medlogics Device Corporation |
Medical device with porous surface containing bioerodable bioactive composites and related methods
|
|
US20060085062A1
(en)
*
|
2003-11-28 |
2006-04-20 |
Medlogics Device Corporation |
Implantable stent with endothelialization factor
|
|
US8252321B2
(en)
*
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
EP1802258A4
(en)
|
2004-09-13 |
2015-09-23 |
Chrono Therapeutics Inc |
BIOSYNCHRONE TRANSDERMAL MEDICINES
|
|
EP1835933A4
(en)
|
2005-01-04 |
2015-01-07 |
Yeda Res & Dev |
HSP60, PEPTIDES HSP60 AND T-CELL VACCINES FOR IMMUNOMODULATION
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
|
WO2006135785A2
(en)
*
|
2005-06-10 |
2006-12-21 |
Medical College Of Georgia Research Institute |
Compositions and methods for treating immune disorders
|
|
US9446017B2
(en)
|
2005-08-11 |
2016-09-20 |
Augusta University Research Institute, Inc. |
Compositions and methods for treating herpes simplex virus
|
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
ES2379117T3
(es)
|
2006-05-16 |
2012-04-20 |
Knopp Neurosciences, Inc. |
Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
JP2010521496A
(ja)
*
|
2007-03-14 |
2010-06-24 |
ノップ ニューロサイエンシーズ、インク． |
キラル精製置換ベンゾチアゾールジアミンの合成
|
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
|
WO2010148409A1
(en)
*
|
2009-06-19 |
2010-12-23 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
US20130017188A1
(en)
|
2009-07-31 |
2013-01-17 |
The Brigham And Women's Hospital, Inc. |
Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
|
|
EP3735944A1
(en)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
EP2556082B1
(en)
|
2010-04-08 |
2017-02-22 |
Emory University |
Substituted androst-4-ene diones
|
|
GB201019761D0
(en)
*
|
2010-11-22 |
2011-01-05 |
Chowdhury Dewan F H |
Multilayered transdermal patch
|
|
CN103732611B
(zh)
|
2011-01-10 |
2016-06-01 |
伊沃恩有限公司 |
β-肾上腺素能反向激动剂用于戒烟的用途
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
|
US9480696B2
(en)
|
2011-05-04 |
2016-11-01 |
Trustees Of Boston University |
Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
|
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
|
EP2543370A1
(en)
|
2011-07-06 |
2013-01-09 |
Georgia Health Sciences University Research Institute, Inc. |
Compositions and Methods for Treating Herpes Simplex Virus
|
|
CA2841785A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
US9243037B2
(en)
|
2011-11-10 |
2016-01-26 |
Trustees Of Boston College |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
|
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
WO2014130922A1
(en)
|
2013-02-25 |
2014-08-28 |
Trustees Of Boston University |
Compositions and methods for treating fungal infections
|
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
LT3019167T
(lt)
|
2013-07-12 |
2021-03-25 |
Knopp Biosciences Llc |
Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
|
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
|
EP3038467B1
(en)
|
2013-08-13 |
2020-07-29 |
Knopp Biosciences LLC |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
|
AU2014306597B2
(en)
|
2013-08-13 |
2018-05-17 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
|
CA2924141C
(en)
|
2013-08-22 |
2022-06-07 |
The General Hospital Corporation |
5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
|
|
EP3038625A4
(en)
|
2013-08-29 |
2017-08-23 |
Trustees of Boston University |
Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
|
|
US9937124B2
(en)
|
2014-09-11 |
2018-04-10 |
International Business Machines Corporation |
Microchip substance delivery devices having low-power electromechanical release mechanisms
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
薬剤送達方法及びシステム
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
EP3303286B1
(en)
|
2015-06-01 |
2023-10-04 |
Cedars-Sinai Medical Center |
Compounds that bind to rela of nf-kb for use in treating cancer
|
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
|
MX2018001075A
(es)
|
2015-07-28 |
2019-04-15 |
Vyome Therapeutics Ltd |
Agentes terapeuticos y profilacticos antibacterianos.
|
|
US10881788B2
(en)
|
2015-10-30 |
2021-01-05 |
International Business Machines Corporation |
Delivery device including reactive material for programmable discrete delivery of a substance
|
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
経皮薬剤送達の装置及び方法
|
|
AU2019279884A1
(en)
|
2018-05-29 |
2020-12-10 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|